PCOS Type Quiz

How the Scales are Structured
Who Usually Takes This Test?
See How You Compare
Below is a preview of how scores are typically distributed across each scale.
Example Questions From the Test
- I have not noticed bleeding between expected periods.
- I noticed one brief episode of light spotting.
- Spotting or bleeding has recurred between periods.
- Unexpected bleeding has been heavy or accompanied by severe pain, weakness, dizziness, or possible pregnancy.
- There is no known recurring loud snoring, gasping, or breathing interruption.
- Occasional snoring has been mentioned, without gasping or daytime effects.
- Loud snoring is frequent, or I regularly wake unrefreshed and struggle with daytime sleepiness.
- Someone has observed repeated pauses, choking, or gasping, or I have dangerous sleepiness during activities such as driving.
- I have not noticed a cluster of these changes.
- One mild change has developed gradually.
- Several changes have gradually become persistent.
- Multiple changes developed quickly, or they include voice deepening or another marked physical change.
PCOS Type Quiz - Description and methodology of the test
For people who notice possible PCOS-related changes, the PCOS Type Quiz offers a way to see which of three signal domains may merit attention. A PCOS symptom assessment can help show where tracking or follow-up may be useful, while keeping the focus on current patterns rather than a clinical label. It is especially useful when recent changes feel confusing, uneven, or difficult to describe clearly.
What This Assessment Explores
Possible signals are grouped into androgen-related changes, menstrual timing and bleeding, and broader metabolic or general-health patterns. Items cover acne, coarse hair, scalp thinning, skin changes, irregular cycles, unexpected bleeding, thirst, urination, weight change, post-meal symptoms, and sleep-breathing concerns.
Items ask whether changes are isolated, persistent, clustered, or rapidly developing; the result summarizes relevant bands. Here, “type” means a profile of current signals across three domains, not a validated clinical PCOS phenotype or subtype. This PCOS health questionnaire helps organize observations.
The three displayed scales are:
- Androgen-Related Patterns (0-15) show No signal noted (0), Noted signal (1-2), or Follow-up signal (3-15) for androgen-related changes.
- Menstrual-Cycle Patterns (0-15) show No signal (0), Noted signal (1-2), or Follow-up signal (3-15) for cycle and bleeding changes.
- Metabolic and General-Health Patterns (0-15) show No signal noted (0), Noted signal (1-2), or Follow-up signal (3-15) for broader health signals.
Methodology and Evidence Base
Each prompt in this self-report questionnaire offers four ordered response choices, moving from no noticed pattern through mild or occasional change to persistent, marked, rapidly developing, or potentially urgent change. Questions add context through recurrence, duration, predictability, and speed of onset, rather than treating every endorsement as equivalent.
Results are reflective summaries, not validated severity, fertility, blood-sugar, cardiovascular, or clinical cutoffs. The questionnaire does not establish a universal point value for each option; a red-flag response scored 3 overrides the total, particularly with sudden physical changes, very heavy bleeding, breathing pauses, or severe metabolic symptoms.
Methodologically, the questionnaire is conceptually consistent with the 2023 International PCOS Guideline and can be read alongside the Rotterdam consensus and Endocrine Society guideline. These are clinical frameworks, not source scales adapted here. For a PCOS self-assessment, honest recall, medications, pregnancy status, life stage, and other conditions affect interpretation. A low band cannot rule out PCOS, while a follow-up band supports professional assessment; rapid or severe symptoms require prompt medical help.
- Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE, International PCOS Network. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. European Journal of Endocrinology. 2023;189(2):G43-G64. 10.1093/ejendo/lvad096
- The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19(1):41-47. 10.1093/humrep/deh098
- Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK, Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. 2013;98(12):4565-4592. 10.1210/jc.2013-2350